ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49165
0.00%
Bitcoin
66,763.87
-0.26%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Opthea Ltd (OPT)

  7. Opthea Ltd (OPT) News

OPT

Opthea (OPT)

Opthea Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPT
DateTimeSourceHeadlineSymbolCompany
14/02/202422:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
01/02/202422:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
11/01/202422:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
27/12/202322:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
27/12/202322:00GlobeNewswire Inc.Opthea to Receive US$35M Commitment and Additional US$50M FundingNASDAQ:OPTOpthea Ltd
19/12/202322:00GlobeNewswire Inc.Opthea Receives A$8.8 million R&D Tax IncentiveNASDAQ:OPTOpthea Ltd
01/12/202321:30GlobeNewswire Inc.Opthea to Present at the FLORetina 2023 CongressNASDAQ:OPTOpthea Ltd
09/11/202322:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
09/11/202321:30GlobeNewswire Inc.Opthea to Present at the Jefferies 2023 London Healthcare ConferenceNASDAQ:OPTOpthea Ltd
30/10/202320:30GlobeNewswire Inc.Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) ConferenceNASDAQ:OPTOpthea Ltd
27/10/202321:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
27/10/202321:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
27/10/202320:30GlobeNewswire Inc.Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFONASDAQ:OPTOpthea Ltd
02/10/202320:30GlobeNewswire Inc.Opthea to Participate at the 2023 Euretina CongressNASDAQ:OPTOpthea Ltd
07/09/202320:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
07/09/202319:30GlobeNewswire Inc.Opthea to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:OPTOpthea Ltd
28/08/202320:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
28/08/202319:30GlobeNewswire Inc.Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)NASDAQ:OPTOpthea Ltd
24/08/202320:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
01/08/202320:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
26/07/202320:00GlobeNewswire Inc.Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302NASDAQ:OPTOpthea Ltd
24/07/202320:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
24/07/202320:00GlobeNewswire Inc.Opthea to Present at the 2023 Ophthalmology Innovation SummitNASDAQ:OPTOpthea Ltd
13/07/202320:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
13/07/202320:00GlobeNewswire Inc.Opthea to Feature at the American Society of Retina Specialists 2023 Annual MeetingNASDAQ:OPTOpthea Ltd
10/07/202320:00GlobeNewswire Inc.Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical AdvisorNASDAQ:OPTOpthea Ltd
08/06/202320:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:OPTOpthea Ltd
08/06/202320:00GlobeNewswire Inc.Opthea Appoints Anshul Thakral as Non-Executive Director of the BoardNASDAQ:OPTOpthea Ltd
25/05/202322:00PR Newswire (Canada)Optiva and lifecell Named as a Nominee in TM Forum's 16th Annual Excellence AwardsNASDAQ:OPTOpthea Ltd
25/05/202320:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:OPTOpthea Ltd
 Showing the most relevant articles for your search:NASDAQ:OPT

Your Recent History

BIT
P20SA3
NLBNPIT20SA3 20241220 5
BIT
P1ZHS5
NLBNPIT1ZHS5 20240918 19...
BOV
B2YN34
Beyond Meat
BIT
P1UKF7
NLBNPIT1UKF7 20351221 17...
BIT
P21L97
NLBNPIT21L97 20240918 21...
BIT
P1W2G8
NLBNPIT1W2G8 20240920 22.5
AMEX
KEM
Kraneshares Dynamic Emer...
NASDAQ
LSPN
Lightspan
BIT
P20F54
NLBNPIT20F54 20351221 44...
BIT
P212K5
NLBNPIT212K5 20991231 12...
BIT
F22204
Vontobel Financial Produ...
BIT
UB6SWC
Unicredit Bank
BIT
P1UOZ7
NLBNPIT1UOZ7 20240621 130
BIT
F18389
Vontobel Financial Produ...
EU
H178S
H178S
BOV
ITUBR368
ITUBR368 Ex:35,5
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved